Skip to content

Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia

Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06512506
Enrollment
47
Registered
2024-07-22
Start date
2022-01-01
Completion date
2024-12-31
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Dysplasia of the Hip

Brief summary

On the basis of the database established in the previous stage, a cohort analysis was conducted on patients with BDDH complicated by hip arthroscopy for minimally invasive treatment of glenoid and lip injury, according to which the indications of minimally invasive surgery for BDDH patients were optimized and surgical measures were improved. Achieve accurate and rapid repair, rehabilitation and functional recovery, serve national fitness, and treat people's injuries

Detailed description

Based on the work of the previous research group, we prospective constructed a bidirectional cohort of patients with critical hip dysplasia, and summarized the influencing factors for the surgical prognosis of patients with BDDH, so as to continuously optimize patient selection. On this basis, the cohort size was extended to analyze the difference in efficacy between arthroscopic glenolabial repair and glenolabial repair combined with soft tissue enhancement, and further improve the minimally invasive surgery to promote the efficacy of minimally invasive surgery in BDDH patients

Interventions

OTHERnon-intervention

non-intervention

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

\- Diagnosis of borderline hip dysplasia with glenolabial injury.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Improved Harris hip scorePreoperative, 24 months after surgeryIt is suitable for the evaluation of therapeutic effect of various hip diseases. The Harris score includes pain, function, deformity and range of motion. The lower the improved Harris score, the worse the postoperative effect.
PRO ratingPreoperative, 24 months after surgeryBased on Patient-Reported Outcome (PRO) : Questionnaires were completed through face-to-face or telephone interviews. Patients' symptoms, function (activity restriction), pain score, quality of life and time to return to activity were evaluated comprehensively. The lower the PRO score, the worse the postoperative effect.
Cartilage damage outerbridge gradingPreoperative, 24 months after surgeryThe patient underwent hip joint MR Examination at 12 months post-operative follow-up with T2 weighted intrachondral defect and high signal

Countries

China

Contacts

Primary ContactJianquan Wang, M.D.
wjqsportsmed@163.com13253137009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026